Core Laboratories (CLB) Tops Q2 EPS by 4c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/19/2026
- S&P 500, Nasdaq advance, turning the page on a tumultuous week
- Oil slides after China asks Iran to limit Houthi attacks on Saudi oil facilities
- Warren Buffett transitions to Berkshire’s chairman emeritus
- Is the S&P 500 in an "earnings bubble"? Goldman weighs in
- Wells Fargo cuts Netflix rating on engagement risk, weak slate
- S&P 500, Nasdaq advance, turning the page on a tumultuous week
- Anthropic and Accenture partner on embedded AI safety evaluation
- Wells Fargo Downgrades Netflix (NFLX) to Underweight on Engagement Risks, 'We see tougher choices ahead'
- Wells Fargo cuts Netflix rating on engagement risk, weak slate
- Is the S&P 500 in an "earnings bubble"? Goldman weighs in
Core Laboratories (CLB) PT Raised to $26 at Cowen
July 24, 2020 8:06 AM EDTCowen analyst Marc Bianchi raised the price target on Core Laboratories (NYSE: CLB) to $26.00 (from $24.00) while maintaining a Market Perform rating.
... MoreCore Laboratories (CLB) PT Raised to $27 at RBC Capital
July 23, 2020 1:58 PM EDTRBC Capital analyst Kurt Hallead raised the price target on Core Laboratories (NYSE: CLB) to $27.00 (from $24.00) while maintaining an Outperform rating.
The analyst commented, "CLB continues to adhere to its long standing financial tenets of maximizing FCF, ROIC and returning excess... More
